We found that six RBPs, including CMSS1, MAEL, THOC5, PSIP1, SNIP1, and ZCCHC7, are significantly related to OS of DLBCL patients, which could potentially be served as prognostic biomarkers. Here, CMSS1 is linked to diffuse large B-cell lymphoma.